Valor Intrínseco del S&P y Nasdaq Contáctenos

Nuwellis, Inc. NUWE NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Nuwellis, Inc. (NUWE) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Eden Prairie, MN, United States. El CEO actual es John L. Erb.

NUWE tiene fecha de IPO 2012-02-16, 38 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $1.11M.

Acerca de Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

📍 12988 Valley View Road, Eden Prairie, MN 55344 📞 952 345 4200
Detalles de la Empresa
SectorSalud
IndustriaMedical - Devices
PaísUnited States
BolsaNASDAQ Capital Marke
MonedaUSD
Fecha de IPO2012-02-16
CEOJohn L. Erb
Empleados38
Información de Negociación
Precio Actual$1.23
Capitalización de Mercado$1.11M
Rango de 52 Semanas0.96-45.36
Beta0.08
ETFNo
ADRNo
CUSIP67113Y702
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje